5-33987241-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_014324.6(AMACR):c.*1852C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.002 in 152,506 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0019 ( 2 hom., cov: 33)
Exomes 𝑓: 0.026 ( 1 hom. )
Consequence
AMACR
NM_014324.6 3_prime_UTR
NM_014324.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.349
Genes affected
AMACR (HGNC:451): (alpha-methylacyl-CoA racemase) This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from this locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also exists between this gene and the upstream neighboring C1QTNF3 (C1q and tumor necrosis factor related protein 3) gene. [provided by RefSeq, Mar 2011]
C1QTNF3-AMACR (HGNC:49198): (C1QTNF3-AMACR readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring C1q and tumor necrosis factor related protein 3 (C1QTNF3) and alpha-methylacyl-CoA racemase (AMACR) genes on chromosome 5. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus not likely to produce a protein product. [provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 5-33987241-G-A is Benign according to our data. Variant chr5-33987241-G-A is described in ClinVar as [Benign]. Clinvar id is 905486.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00194 (295/152114) while in subpopulation SAS AF= 0.0185 (89/4820). AF 95% confidence interval is 0.0154. There are 2 homozygotes in gnomad4. There are 162 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMACR | NM_014324.6 | c.*1852C>T | 3_prime_UTR_variant | 5/5 | ENST00000335606.11 | NP_055139.4 | ||
AMACR | NM_001167595.2 | c.*1067C>T | 3_prime_UTR_variant | 6/6 | NP_001161067.1 | |||
AMACR | NM_203382.3 | c.*2243C>T | 3_prime_UTR_variant | 4/4 | NP_976316.1 | |||
C1QTNF3-AMACR | NR_037951.1 | n.3357C>T | non_coding_transcript_exon_variant | 9/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMACR | ENST00000335606 | c.*1852C>T | 3_prime_UTR_variant | 5/5 | 1 | NM_014324.6 | ENSP00000334424.6 | |||
AMACR | ENST00000382072.6 | c.*2243C>T | 3_prime_UTR_variant | 4/4 | 1 | ENSP00000371504.2 | ||||
C1QTNF3-AMACR | ENST00000382079.3 | n.*2427C>T | non_coding_transcript_exon_variant | 9/9 | 2 | ENSP00000371511.3 | ||||
C1QTNF3-AMACR | ENST00000382079.3 | n.*2427C>T | 3_prime_UTR_variant | 9/9 | 2 | ENSP00000371511.3 |
Frequencies
GnomAD3 genomes AF: 0.00196 AC: 298AN: 151996Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
298
AN:
151996
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0255 AC: 10AN: 392Hom.: 1 Cov.: 0 AF XY: 0.0294 AC XY: 6AN XY: 204
GnomAD4 exome
AF:
AC:
10
AN:
392
Hom.:
Cov.:
0
AF XY:
AC XY:
6
AN XY:
204
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00194 AC: 295AN: 152114Hom.: 2 Cov.: 33 AF XY: 0.00218 AC XY: 162AN XY: 74352
GnomAD4 genome
AF:
AC:
295
AN:
152114
Hom.:
Cov.:
33
AF XY:
AC XY:
162
AN XY:
74352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
23
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Alpha-methylacyl-CoA racemase deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at